Jasper Therapeutics Inc.-CW26JSPRWPreferred / convertible
13F holders, Q2 2026 (June 30)7holders
1new positions
1sold out
$0.06avg. 13F price*
At the end of Q2 2026, 7 institutions reported holding Jasper Therapeutics Inc.-CW26 (JSPRW) in their 13F filings, unchanged from Q1 2026. 1 opened new positions and 1 sold out. The largest holders were Boothbay Fund Management, LLC ($150K), Toronto Dominion Bank ($30K) and TENOR CAPITAL MANAGEMENT Co., L.P. ($3K).
- Company
- Jasper Therapeutics Inc.-CW26
- CUSIP
- 471871111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $618 |
All 13F filers, Q1 2026 → Q2 2026: 902 shares bought and 28,300 shares sold, net −27,398 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Boothbay Fund Management, LLC | — | No change | 357,447 | $150K |
| Toronto Dominion Bank | — | Reduce 0.0% | 2,174,682 | $30K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 250,000 | $3K |
| Walleye Capital LLC | — | No change | 200,000 | $3K |
| Wolverine Asset Management LLC | — | Add +57.8% | 1,639 | $22 |
| IFP Advisors, Inc | — | No change | 50 | $1 |
| SkyView Investment Advisors, LLC | — | New | 302 | $0 |
"% of holder's portfolio" is JSPRW's weight in each manager's 13F, not the share of Jasper Therapeutics Inc.-CW26 the manager owns.